|
Re: Patience
|
5
|
Resverlogix Corp.
|
Jun 19, 2021 04:14PM
|
|
Re: Price
|
5
|
Resverlogix Corp.
|
Dec 30, 2020 05:14PM
|
|
Re: Good post SanFran
|
5
|
Zenith Epigenetics
|
May 29, 2019 06:30PM
|
|
The investing worlds' assessment on RVX!
|
5
|
Resverlogix Corp.
|
Feb 23, 2021 08:59AM
|
|
Re: Recap / webcast / blackout...
|
5
|
Resverlogix Corp.
|
Feb 28, 2016 09:14AM
|
|
Re: SP 52 week low
|
5
|
Resverlogix Corp.
|
Oct 06, 2022 12:30PM
|
|
Re: Gut Feeling
|
5
|
Resverlogix Corp.
|
Oct 02, 2019 06:02PM
|
|
Re: BTI press release
|
5
|
BIOASIS TECHNOLOGIES INC
|
Jun 24, 2021 06:59AM
|
|
Re: GROWACET - OTC?
|
5
|
Resverlogix Corp.
|
Oct 16, 2019 02:22PM
|
|
Re: Option #2
|
5
|
Resverlogix Corp.
|
Sep 11, 2020 07:14AM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
5
|
Zenith Epigenetics
|
Feb 19, 2022 04:31PM
|
|
Re: How is Zenith affected by the RVX top line miss
|
5
|
Zenith Epigenetics
|
Oct 01, 2019 08:54AM
|
|
Re: ZHCLF
|
5
|
Zenith Epigenetics
|
Feb 02, 2024 07:27AM
|
|
Re: Worth noting imo. Of concern …?
|
5
|
Resverlogix Corp.
|
Feb 06, 2024 08:50AM
|
|
FUD!
|
5
|
Resverlogix Corp.
|
Oct 13, 2019 12:46PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 01:34PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Jan 15, 2018 05:26PM
|
|
Re: Level ll on the sell side.
|
5
|
Resverlogix Corp.
|
Apr 19, 2021 04:16PM
|
|
Re: i didn't waste my time
|
5
|
Resverlogix Corp.
|
May 02, 2018 11:29AM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 08:40AM
|
